Clinical studyDefective release of tissue plasminogen activator in systemic and cutaneous vasculitis☆
References (18)
- et al.
Venous and arterial thromboembolic disease in women taking oral contraceptives
Am J Obstet Gynecol
(1982) - et al.
Vascular plasminogen activator levels and thromboembolic disease in patients with gynecologic malignancies
Am J Obstet Gynecol
(1984) - et al.
The spectrum of vasculitis
Ann Intern Med
(1978) - et al.
Coagulation and fibrinolysis in young female arteritis
Acta Med Scand
(1971) - et al.
Behcet's disease with decreased fibrinolysis and superior vena caval obstruction
Br Med J
(1973) - et al.
Decreased fibrinolysis in Behcet's disease
Thromb Diath Haemorrh
(1973) - et al.
Studies on the blood fibrinolytic enzyme system of patients with cutaneous vasculitis
Br J Dermatol
(1980) - et al.
Skin fibrinolytic activity in cutaneous and systemic vasculitis
Mayo Clin Proc
(1976) - et al.
The association between cutaneous vasculitis and decreased blood fibrinolytic activity
Br J Dermatol
(1971)
There are more references available in the full text version of this article.
Cited by (46)
Coagulation and fibrinolysis in cutaneous vasculitis
1999, Clinics in DermatologyCellular steps in pathogenesis of cutaneous necrotizing vasculitis
1999, Clinics in DermatologyCutaneous small-vessel vasculitis
1998, Journal of the American Academy of DermatologyFibrinolytic abnormalities in two different cutaneous manifestations of venous disease
1996, Journal of the American Academy of DermatologyVascular thromboses with retroperitoneal fibrosis: a case report
2022, Journal of Medical Case Reports
- ☆
This work was supported by Research Grants HL-31932 and HL-24066 from the National Heart, Lung, and Blood Institute.
Copyright © 1987 Published by Excerpta Medica Inc.